quantisnow
FeedTopReportsPricing
⌘K
Live feed
16:06:09·9d
SECFiling
Enveric Biosciences Inc. logo

SEC Form DEFA14A filed by Enveric Biosciences Inc.

ENVB· Enveric Biosciences Inc.
Health Care
Original source

Companies

  • ENVB
    Enveric Biosciences Inc.
    Health Care

Recent analyst ratings

  • Mar 8UpdateAegis Capital$0.20
  • Jul 8UpdateAegis Capital$7.00
  • Jun 28UpdateMaxim Group$6.00

Related

  • SEC7h
    SEC Form S-3 filed by Enveric Biosciences Inc.
  • PR2d
    Enveric Biosciences to Participate in a Panel Discussion at Needham's Virtual Psychedelics Forum
  • PR6d
    Enveric Biosciences Announces Closing of Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules
  • PR7d
    Enveric Biosciences Announces Up To $13.9 Million Private Placement Priced At-The-Market Under Nasdaq Rules
  • SEC9d
    SEC Form DEF 14A filed by Enveric Biosciences Inc.
  • SEC20d
    SEC Form PRE 14A filed by Enveric Biosciences Inc.
  • PR23d
    Enveric Biosciences Secures New U.S. Patent for Its EVM301 Series of Drug Candidates
  • PR27d
    Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022